Department of Microbiology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
J Clin Microbiol. 2012 Dec;50(12):3893-900. doi: 10.1128/JCM.01622-12. Epub 2012 Sep 26.
Helicobacter cinaedi is the most frequently reported enterohepatic Helicobacter species isolated from humans. Earlier research suggested that certain patients with H. cinaedi infection may remain undiagnosed or incorrectly diagnosed because of difficulties in detecting the bacteria by conventional culture methods. Here, we report a nested PCR assay that rapidly detects the cytolethal distending toxin gene (cdt) of H. cinaedi with high specificity and sensitivity. Specificity of the assay was validated by using different species of Helicobacter and Campylobacter, as well as known H. cinaedi-positive and -negative samples. The sensitivity of detection for the cdt gene in the assay was 10(2) CFU/ml urine or 10(2) CFU/10(5) infected RAW 264.7 cells. In an H. cinaedi-infected mouse model, the cdt gene of H. cinaedi was effectively detected via the assay with urine (6/7), stool (2/3), and blood (2/6) samples. Importantly, it detected H. cinaedi in blood, urine, and stool samples from one patient with a suspected H. cinaedi infection and three patients with known infections. The assay was further used clinically to follow up two H. cinaedi-infected patients after antibiotic treatment. Stool samples from these two patients evaluated by nested PCR after antibiotic therapy showed clearance of bacterial DNA. Finally, analysis of stool specimens from healthy volunteers showed occasional positive reactions (4/30) to H. cinaedi DNA, which suggests intestinal colonization by H. cinaedi in healthy subjects. In conclusion, this nested PCR assay may be useful for the rapid diagnosis, antimicrobial treatment evaluation, and epidemiological study of H. cinaedi infection.
脆弱拟杆菌是从人类中分离出的最常报告的肠肝脆弱拟杆菌种。早期研究表明,由于常规培养方法检测细菌的困难,某些脆弱拟杆菌感染患者可能未被诊断或误诊。在这里,我们报告了一种巢式 PCR 检测方法,该方法可快速检测脆弱拟杆菌的细胞扩张毒素基因(cdt),具有高特异性和灵敏度。该检测方法的特异性通过使用不同种属的幽门螺杆菌和弯曲菌以及已知的脆弱拟杆菌阳性和阴性样本进行验证。检测 cdt 基因的检测灵敏度为 10(2)CFU/ml 尿液或 10(2)CFU/10(5)感染 RAW 264.7 细胞。在脆弱拟杆菌感染的小鼠模型中,该检测方法可有效检测尿液(6/7)、粪便(2/3)和血液(2/6)样本中的 cdt 基因。重要的是,它在一名疑似脆弱拟杆菌感染患者和三名已知感染者的血液、尿液和粪便样本中检测到了脆弱拟杆菌。该检测方法还进一步用于临床随访两名接受抗生素治疗的脆弱拟杆菌感染患者。经抗生素治疗后,对这些两名患者的粪便样本进行嵌套 PCR 评估,显示细菌 DNA 清除。最后,对健康志愿者的粪便标本进行分析,发现偶尔有脆弱拟杆菌 DNA 呈阳性反应(4/30),这表明健康受试者存在脆弱拟杆菌肠道定植。总之,这种巢式 PCR 检测方法可能有助于快速诊断、抗菌治疗评估和脆弱拟杆菌感染的流行病学研究。